Follow
Jorge R. Georgakopoulos
Jorge R. Georgakopoulos
Division of Dermatology, Department of Medicine, University of Toronto
Verified email at mail.utoronto.ca
Title
Cited by
Cited by
Year
Facial and neck erythema associated with dupilumab treatment: a systematic review
CE Jo, A Finstad, JR Georgakopoulos, V Piguet, J Yeung, AM Drucker
Journal of the American Academy of Dermatology 84 (5), 1339-1347, 2021
802021
Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: a multicenter retrospective study of interleukin 17A antagonist therapies
JR Georgakopoulos, M Phung, A Ighani, J Yeung
Journal of the American Academy of Dermatology 79 (1), 155-157, 2018
522018
Drug survival of secukinumab in real-world plaque psoriasis patients: a 52-week, multicenter, retrospective study
JR Georgakopoulos, A Ighani, M Phung, J Yeung
Journal of the American Academy of Dermatology 78 (5), 1019-1020, 2018
442018
Biologic switching between interleukin 17A antagonists secukinumab and ixekizumab: a 12-week, multicenter, retrospective study.
JR Georgakopoulos, M Phung, A Ighani, K Lam, J Yeung
Journal of the European Academy of Dermatology and Venereology: JEADV 33 (1 …, 2018
322018
Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real-world Canadian dermatology clinics: a multicenter retrospective study.
JR Georgakopoulos, A Ighani, LL Zhou, J Yeung
Journal of the European Academy of Dermatology and Venereology: JEADV 32 (1 …, 2017
322017
Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter …
A Ighani, JR Georgakopoulos, NH Shear, S Walsh, J Yeung
Journal of the American Academy of Dermatology 78 (4), 801-803, 2018
302018
Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: a retrospective cohort study
CE Jo, JR Georgakopoulos, M Ladda, A Ighani, A Mufti, AM Drucker, ...
Journal of the American Academy of Dermatology 82 (6), 1530-1532, 2020
292020
A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: a Canadian multicenter retrospective study
A Ighani, JR Georgakopoulos, S Walsh, NH Shear, J Yeung
Journal of the American Academy of Dermatology 78 (3), 623-626, 2018
262018
Efficacy and safety of apremilast monotherapy for moderate to severe psoriasis: retrospective study
A Ighani, JR Georgakopoulos, LL Zhou, S Walsh, N Shear, J Yeung
Journal of Cutaneous Medicine and Surgery 22 (3), 290-296, 2018
232018
Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: a Canadian multicenter retrospective study
JR Georgakopoulos, A Mufti, R Vender, J Yeung
Journal of the American Academy of Dermatology 83 (4), 1212-1214, 2020
222020
Ixekizumab (interleukin 17A antagonist): 12-week efficacy and safety outcomes in real-world clinical practice
JR Georgakopoulos, M Phung, A Ighani, J Yeung
Journal of Cutaneous Medicine and Surgery 23 (2), 174-177, 2019
192019
Secukinumab dose optimization in adult psoriasis patients: a retrospective, multicenter case series
M Phung, JR Georgakopoulos, A Ighani, L Giroux, J Yeung
JAAD Case Reports 4 (4), 310-313, 2018
192018
Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study
JR Georgakopoulos, D Croitoru, T Felfeli, R Alhusayen, P Lansang, ...
Journal of the American Academy of Dermatology 85 (4), 1049-1051, 2021
182021
Systemic monotherapy treatments for generalized pustular psoriasis: a systematic review
LL Zhou, JR Georgakopoulos, A Ighani, J Yeung
Journal of Cutaneous Medicine and Surgery 22 (6), 591-601, 2018
182018
Short-and long-term management of an acute pustular psoriasis flare: a case report
JR Georgakopoulos, A Ighani, J Yeung
Journal of Cutaneous Medicine and Surgery 21 (5), 452-456, 2017
182017
The chemoattractant potential of ginsenosides in the ginseng–Pythium irregulare pathosystem
DA Ivanov, JRC Georgakopoulos, MA Bernards
Phytochemistry 122, 56-64, 2016
172016
Numerous asymptomatic dermal cysts: diagnosis and treatment of steatocystoma multiplex
JR Georgakopoulos, A Ighani, J Yeung
Canadian Family Physician 64 (12), 892-899, 2018
152018
Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: a real-world Canadian multicenter retrospective study
JR Georgakopoulos, T Felfeli, AM Drucker, CE Jo, V Piguet, J Yeung
JAAD international 4, 67, 2021
142021
Patient-driven discontinuation of dupilumab during the COVID-19 pandemic in two academic hospital clinics at the University of Toronto
JR Georgakopoulos, J Yeung
Journal of Cutaneous Medicine and Surgery 24 (4), 422-423, 2020
132020
Incidence of COVID-19 in patients with chronic idiopathic urticaria and asthma on omalizumab: a multicentre retrospective cohort study
A Abduelmula, JR Georgakopoulos, A Mufti, AR Devani, MJ Gooderham, ...
Journal of cutaneous medicine and surgery 26 (3), 319-320, 2022
122022
The system can't perform the operation now. Try again later.
Articles 1–20